Four things to know:
1. Allscripts expects to grow its provider space, which comprises EHRs in both the acute and ambulatory settings, 2.5 percent to 3 percent by 2022.
2. The company’s payer and life sciences division Veradigm is projected to increase at a compound annual growth rate of 15 percent to 25 percent over the next three years. Based on that estimation, Allscripts aims secure a 3.5 percent to 6 percent non-GAAP growth rate.
3. Allscripts plans to increase its merger and acquisition revenues by 2 percent to 3 percent over the next three years.
4. Collectively, the company anticipates growing its revenues at a 5.5 percent to 9 percent CAGR by 2022.
More articles on EHRs:
Nearly 1 in 3 eye care patients’ EHR may pose medication discrepancy, study finds
Physician viewpoint: Surgeons ‘shielded’ from certain paperwork, administrative tasks that cause burnout
HIMSS’ EHR association raises concerns about ONC’s proposed interoperability rule
